Home
Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 23/01/18
Trade details
- Type
- Insider sale
- Amount
- $972,857.76
- Shares · price
- 3,732 sh · $260.68 a share
- Held after
- 1,000 sh
- Trade date
- 23/01/17
- Filed
- 23/01/18
- Days to filing
- 1 days
Sold 78.9% of holdings
- Share of holding sold
- 78.9%
United Therapeutics trades, last 26 weeks
What else happened in United Therapeutics around then
Filed or reported within 30 days of the trade day · 22/12/18~23/02/16Martine A. Rothblatt's recent trades
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$1.1M
2,309 sh
$1.1M
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$1M
2,135 sh
$1M
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$664.2K
1,395 sh
$664.2K
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$574.9K
1,200 sh
$574.9K
Filed 09/30
Traded 09/29
- Martine A. Rothblatt
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 planUnited Therapeutics
UTHR
$262.3K
552 sh
$262.3K
Filed 09/30
Traded 09/29